Hepion Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Hepion Pharmaceuticals, Inc.

May-12	Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq GlobeNewswire
May-07	Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information